234 related articles for article (PubMed ID: 19897215)
21. Euphorbia Kansui Reactivates Latent HIV.
Cary DC; Fujinaga K; Peterlin BM
PLoS One; 2016; 11(12):e0168027. PubMed ID: 27977742
[TBL] [Abstract][Full Text] [Related]
22. Bioactive jatrophane diterpenes from Euphorbia guyoniana.
Hegazy ME; Mohamed Ael-H; Aoki N; Ikeuchi T; Ohta E; Ohta S
Phytochemistry; 2010 Feb; 71(2-3):249-53. PubMed ID: 19900686
[TBL] [Abstract][Full Text] [Related]
23. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
Li XD; Moore B; Cloyd MW
Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
[TBL] [Abstract][Full Text] [Related]
24. Compounds producing an effective combinatorial regimen for disruption of HIV-1 latency.
Hashemi P; Barreto K; Bernhard W; Lomness A; Honson N; Pfeifer TA; Harrigan PR; Sadowski I
EMBO Mol Med; 2018 Feb; 10(2):160-174. PubMed ID: 29246970
[TBL] [Abstract][Full Text] [Related]
25. Antiviral activities of extracts of Euphorbia hirta L. against HIV-1, HIV-2 and SIVmac251.
Gyuris A; Szlávik L; Minárovits J; Vasas A; Molnár J; Hohmann J
In Vivo; 2009; 23(3):429-32. PubMed ID: 19454510
[TBL] [Abstract][Full Text] [Related]
26. Topical anti-inflammatory effect of tirucallol, a triterpene isolated from Euphorbia lactea latex.
Fernandez-Arche A; Saenz MT; Arroyo M; de la Puerta R; Garcia MD
Phytomedicine; 2010 Feb; 17(2):146-8. PubMed ID: 19577446
[TBL] [Abstract][Full Text] [Related]
27. Administration of HDAC inhibitors to reactivate HIV-1 expression in latent cellular reservoirs: implications for the development of therapeutic strategies.
Demonté D; Quivy V; Colette Y; Van Lint C
Biochem Pharmacol; 2004 Sep; 68(6):1231-8. PubMed ID: 15313421
[TBL] [Abstract][Full Text] [Related]
28. Establishment of latent HIV-1 infection of resting CD4(+) T lymphocytes does not require inactivation of Vpr.
Shen A; Siliciano JD; Pierson TC; Buck CB; Siliciano RF
Virology; 2000 Dec; 278(1):227-33. PubMed ID: 11112497
[TBL] [Abstract][Full Text] [Related]
29. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.
Chun TW; Carruth L; Finzi D; Shen X; DiGiuseppe JA; Taylor H; Hermankova M; Chadwick K; Margolick J; Quinn TC; Kuo YH; Brookmeyer R; Zeiger MA; Barditch-Crovo P; Siliciano RF
Nature; 1997 May; 387(6629):183-8. PubMed ID: 9144289
[TBL] [Abstract][Full Text] [Related]
30. Rearranged jatrophane-type diterpenes from euphorbia species. Evaluation of their effects on the reversal of multidrug resistance.
Madureira AM; Ferreira MJ; Gyémánt N; Ugocsai K; Ascenso JR; Abreu PM; Hohmann J; Molnár J
Planta Med; 2004 Jan; 70(1):45-9. PubMed ID: 14765292
[TBL] [Abstract][Full Text] [Related]
31. Hidden HIV reservoirs: will eradication of the virus be possible?
Gomez E
Newsline People AIDS Coalit N Y; 1998 Mar; ():18-9. PubMed ID: 11367451
[TBL] [Abstract][Full Text] [Related]
32. Approaching eradication of highly active antiretroviral therapy-persistent human immunodeficiency virus type 1 reservoirs with immune activation therapy.
Kulkosky J; Pomerantz RJ
Clin Infect Dis; 2002 Dec; 35(12):1520-6. PubMed ID: 12471572
[TBL] [Abstract][Full Text] [Related]
33. The development of immune-modulating compounds to disrupt HIV latency.
Remoli AL; Marsili G; Battistini A; Sgarbanti M
Cytokine Growth Factor Rev; 2012; 23(4-5):159-72. PubMed ID: 22766356
[TBL] [Abstract][Full Text] [Related]
34. Reservoirs of HIV-1 in vivo: implications for antiretroviral therapy.
Saksena NK; Potter SJ
AIDS Rev; 2003; 5(1):3-18. PubMed ID: 12875103
[TBL] [Abstract][Full Text] [Related]
35. Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies.
Quivy V; De Walque S; Van Lint C
Subcell Biochem; 2007; 41():371-96. PubMed ID: 17484137
[TBL] [Abstract][Full Text] [Related]
36. Jatrophane diterpenes from the latex of Euphorbia obtusifolia with inhibitory activity on the mammalian mitochondrial respiratory chain.
Betancur-Galvis L; Checa J; Marco JA; Estornell E
Planta Med; 2003 Feb; 69(2):177-8. PubMed ID: 12624829
[TBL] [Abstract][Full Text] [Related]
37. HIV-1 reactivation induced by apicidin involves histone modification in latently infected cells.
Lin S; Zhang Y; Ying H; Zhu H
Curr HIV Res; 2011 Jun; 9(4):202-8. PubMed ID: 21631428
[TBL] [Abstract][Full Text] [Related]
38. A new cytotoxic cembrane diterpene from the roots of Euphorbia pekinensis Rupr.
Hou P; Zeng Y; Ma B; Bi K; Chen X
Fitoterapia; 2013 Oct; 90():10-3. PubMed ID: 23850541
[TBL] [Abstract][Full Text] [Related]
39. Procyanidin trimer C1 derived from Theobroma cacao reactivates latent human immunodeficiency virus type 1 provirus.
Hori T; Barnor J; Nguyen Huu T; Morinaga O; Hamano A; Ndzinu J; Frimpong A; Minta-Asare K; Amoa-Bosompem M; Brandful J; Odoom J; Bonney J; Tuffour I; Owusu BA; Ofosuhene M; Atchoglo P; Sakyiamah M; Adegle R; Appiah-Opong R; Ampofo W; Koram K; Nyarko A; Okine L; Edoh D; Appiah A; Uto T; Yoshinaka Y; Uota S; Shoyama Y; Yamaoka S
Biochem Biophys Res Commun; 2015 Apr; 459(2):288-293. PubMed ID: 25727021
[TBL] [Abstract][Full Text] [Related]
40. Harmine enhances the activity of the HIV-1 latency-reversing agents ingenol A and SAHA.
Taylor JP; Armitage LH; Aldridge DL; Cash MN; Wallet MA
Biol Open; 2020 Dec; 9(12):. PubMed ID: 33234703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
